Bristol-Myers Squibb and the Otsuka Pharmaceutical Company market Abilify as an add-on treatment to other anti-depressants and as a treatment for other mental illnesses. But the blockbuster drug is also linked to serious side effects like suicidal thoughts, sexual dysfunction and compulsive gambling.
What is Abilify?
If you are one of millions of Americans who live with major depression, bipolar disorder or schizophrenia, atypical antipsychotic drugs like Abilify can make a difference in your quality of life. Mental illnesses can cripple, and doctors prescribe these drugs to manage symptoms and help people live more normal lives.
The Otsuka Phamaceutical Co. developed Abilify (aripiprazole), and the U.S. Food and Drug Administration (FDA) first approved it in 2002 as a treatment for schizophrenia. Otsuka partnered with Bristol-Myers Squibb to market it.